Retraction notice to “Piceatannol Suppresses endotoxin-induced ocular inflammation in Rats” [International Immunopharmacology 17/2 (2013) 439 - 446] (International Immunopharmacology (2013) 17(2) (439–446), (10.1016/j.intimp.2013.07.007)(S1567576913002920));Piceatannol suppresses endotoxin-induced ocular inflammation in rats

International Immunopharmacology

Volumn 17, Issue 2, 2013, Pages 439-446

  Kalariya, Nilesh M ^a,b   Shoeb, Mohammad ^a   Reddy, Aramati B M ^a   Sawhney, Rahul ^a   Ramana, Kota V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Inflammation NF B Rats; Piceatannol; Uveitis

Indexed keywords

CYCLOOXYGENASE 2; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PICEATANNOL; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UVEITIS; WESTERN BLOTTING;

INFLAMMATION; NF-ΚB; PICEATANNOL; RATS; UVEITIS;

ANIMALS; AQUEOUS HUMOR; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; HUMANS; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED LEW; RETINA; SHOCK, SEPTIC; STILBENES; UVEITIS;

EID: 84880987345     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2016.10.022     Document Type: Erratum

References (36)

1. Nguyen QD, Hatef E, Kayen B, Macahilig CP, IbrahimM, Wang J, et al. A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Ophthalmology 2011;18:184-90.
2. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol 1990;14:303-8. (Pubitemid 20350862)
3. de Vos AF, Klaren VN, Kijlstra A. Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994;35:3873-83. (Pubitemid 24334545)
4. Sijssens KM, Rijkers GT, Rothova A, Stilma JS, de Boer JH. Distinct cytokine patterns in the aqueous humor of children, adolescents and adults with uveitis. Ocul Immunol Inflamm 2008;16:211-6.
5. Kim EY, Moudgil KD. Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol Lett 2008;30:1-5.
6. CurnowSJ,Murray PI. Inflammatorymediators of uveitis: cytokines and chemokines. Curr Opin Ophthalmol 2006;17:532-7.
7. Kalariya NM, Shoeb M, Reddy AB, Zhang M, van Kuijk FJ, Ramana KV, et al. Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone. Invest Ophthalmol Vis Sci 2010;51:5105-13.
8. Kalariya NM, Reddy AB, Ansari NH, VanKuijk FJ, Ramana KV. Preventive effects of ethyl pyruvate on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2011;52:5144-51452.
9. Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 2000;11:478-83.
10. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24:2783-840. (Pubitemid 39409568)
11. Piotrowska H, Kucinska M, Murias M. Biological activity of piceatannol: Leaving the shadow of resveratrol. Mutat Res 2012;750:60-82.
12. Rhayem Y, Therond P, Camont L, Couturier M, Beaudeux JL, Legrand A, et al. Chain-breaking activity of resveratrol and piceatannol in a linoleate micellar model. Chem Phys Lipids 2008;155:48-56.
13. Ovesna Z, Kozics K, Bader Y, Saiko P, Handler N, Erker T, et al. Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'- hexahydroxytrans-stilbene in three leukemia cell lines. Oncol Rep 2006;16:617-24.
14. Wung BS, Hsu MC, Wu CC, Hsieh CW. Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways. Pharmacol Res 2006;53:113-22.
15. Makena PS, Chung KT. Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity. Food Chem Toxicol 2007;45:1899-909. (Pubitemid 47238204)
16. Wesolowska O, Kuzdzal M, Strancar J, Michalak K. Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes. Biochim Biophys Acta 2009;1788:1851-60.
17. LarrosaM, Tomas-Barberan FA, Espin JC. The grape andwine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. Eur J Nutr 2005;43:275-84. (Pubitemid 39377761)
18. Morales P, Haza AI. Selective apoptotic effects of piceatannol and myricetin in human cancer cells. J Appl Toxicol 2012;32:986-93.
19. Choi KH, Kim JE, Song NR, Son JE, Hwang MK, Byun S, et al. Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovasc Res 2010;85: 836-44.
20. Caspi RR. Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol 2003:15.6.1-15.6.20.
21. Saxena A, Tammali R, Ramana KV, Sriavastava SK. Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a. Antioxid Redox Signal 2013;18: 1249-62.
22. Yadav UC, Shoeb M, Srivastava SK, Ramana KV. Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice. Invest Ophthalmol Vis Sci 2011;52:8076-85.
23. Jin XH, Ohgami K, Shiratori K, Suzuki Y, Hirano T, Koyama Y, et al. Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci 2006;47:2562-8. (Pubitemid 351639842)
24. Kim YH, Kwon HS, Kim DH, Cho HJ, Lee HS, Jun JG, et al. Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium-induced colitis. Int Immunopharmacol 2008;8:1695-702.
25. Richard N, Porath D, Radspieler A, Schwager J. Effects of resveratrol, piceatannol, tri-acetoxystilbene, and genistein on the inflammatory response of human peripheral blood leukocytes. Mol Nutr Food Res 2005;49:431-42. (Pubitemid 40780390)
26. Wang J, Lu H, Hu X, Chen W, Xu Z, Li S, et al. Nuclear factor translocation and acute anterior uveitis. Mol Vis 2011;17:170-6.
27. Keino H. Therapeutic effect of the low molecular weight inhibitor of the NF-kappaB signaling pathway on experimental autoimmune uveoretinitis. Nippon Ganka Gakkai Zasshi 2010;114:944-54.
28. Suzuki Y, Ohgami K, Shiratori K, Jin XH, Ilieva I, Koyama Y, et al. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway. Exp Eye Res 2006;82:275-81. (Pubitemid 43122113)
29. Yadav UC, Srivastava SK, Ramana KV. Aldose reductase inhibition prevents endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2007;48:4634-42. (Pubitemid 351260981)
30. Jin H, Yang X, Liu K, Gu Q, Xu X. Effects of a novel peptide derived from human thrombomodulin on endotoxin-induced uveitis in vitro and in vivo. FEBS Lett 2011;585:3457-64.
31. Suzuki J, Manola A, Murakami Y, Morizane Y, Takeuchi K, Kayama M, et al. Inhibitory effect of aminoimidazole carboxamide ribonucleotide (AICAR) on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2011;52:6565-71.
32. Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S, Aggarwal BB. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha and p65 phosphorylation. J Immunol 2002;169:6490-7. (Pubitemid 36903500)
33. Son PS, Park SA, Na HK, Jue DM, KimS, Surh YJ. Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-{kappa}B activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKK{beta} as a potential target. Carcinogenesis 2010;31:1442-9.
34. Jin CY, Moon DO, Lee KJ, Kim MO, Lee JD, Choi YH, et al. Piceatannol attenuates lipopolysaccharide-induced NF-kappaB activation and NF-kappaB-related proinflammatory mediators in BV2 microglia. Pharmacol Res 2006;54:461-7. (Pubitemid 46075095)
35. Youn J, Lee JS, Na HK, Kundu JK, Surh YJ. Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-inducedmouse colitis. Nutr Cancer 2009;61:847-54.
36. Liu D, Kim DH, Park JM, Na HK, Surh YJ. Piceatannol inhibits phorbol ester-induced NF-kappa B activation and COX-2 expression in cultured human mammary epithelial cells. Nutr Cancer 2009;61:855-63.